Transferrin-Pep63-liposomes accelerate the clearance of Aβ and rescue impaired synaptic plasticity in early Alzheimer's disease models

X Yang, X Li, L Liu, YH Chen, Y You, Y Gao… - Cell Death …, 2021 - nature.com
Alzheimer's disease (AD) is characterized by aberrant accumulation of extracellular β-
amyloid (Aβ) peptides in the brain. Soluble Aβ oligomers are thought to be the most …

Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models

C Balducci, S Mancini, S Minniti… - Journal of …, 2014 - Soc Neuroscience
Alzheimer's disease is characterized by the accumulation and deposition of plaques of β-
amyloid (Aβ) peptide in the brain. Given its pivotal role, new therapies targeting Aβ are in …

Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood–brain-barrier: Implications for …

L Bana, S Minniti, E Salvati, S Sesana… - … , Biology and Medicine, 2014 - Elsevier
Targeting amyloid-β peptide (Aβ) within the brain is a strategy actively sought for therapy of
Alzheimer's disease (AD). We investigated the ability of liposomes bi-functionalized with …

Liposome delivery systems for the treatment of Alzheimer's disease

C Ross, M Taylor, N Fullwood… - International journal of …, 2018 - Taylor & Francis
Alzheimer's disease (AD) will affect around 115 million people worldwide by the year 2050.
It is associated with the accumulation of misfolded and aggregated proteins (β-amyloid and …

The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease

S Mancini, S Minniti, M Gregori, G Sancini… - … , Biology and Medicine, 2016 - Elsevier
We previously showed the ability of liposomes bi-functionalized with phosphatidic acid and
an ApoE-derived peptide (mApoE-PA-LIP) to reduce brain Aβ in transgenic Alzheimer mice …

Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells

E Bereczki, F Re, ME Masserini, B Winblad… - … , Biology and Medicine, 2011 - Elsevier
The loss of synapses and neurons in Alzheimer's disease (AD) is thought to be at least partly
induced by toxic species formed by the amyloid beta (Aβ) peptide; therefore, therapeutics …

Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease

S Senapati, K Tripathi, K Awad, S Rahimipour - Small, 2024 - Wiley Online Library
Early detection and treatment are crucial for Alzheimer's disease (AD) management. Current
diagnostic and therapeutic methods focus on late‐stage amyloid fibrils and plaques …

Identification of polyphenolic compounds and black tea extract as potent inhibitors of lipid membrane destabilization by Aβ 42 aggregates

AJ Gauci, M Caruana, A Giese… - Journal of …, 2011 - content.iospress.com
Amyloid-β (Aβ) aggregation is a recognized key process in the pathogenesis of Alzheimer's
disease (AD). Misfolded Aβ peptides self-assemble into higher-order oligomers that …

Inhibition of amyloid beta-induced synaptotoxicity by a pentapeptide derived from the glycine zipper region of the neurotoxic peptide

C Peters, EJ Fernandez-Perez, CF Burgos… - Neurobiology of …, 2013 - Elsevier
A major characteristic of Alzheimer's disease is the presence of amyloid beta (Aβ) oligomers
and aggregates in the brain. Aβ oligomers interact with the neuronal membrane inducing …

Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease

E Conti, M Gregori, I Radice, F Da Re, D Grana… - Neurochemistry …, 2017 - Elsevier
The accumulation of extracellular amyloid beta (Abeta42) both in brain and in cerebral
vessels characterizes Alzheimer's disease (AD) pathogenesis. Recently, the possibility to …